Results 211 to 220 of about 63,222 (303)
Neuromodulation for Pain Management: Evidence of Safety and Efficacy. [PDF]
Molero-Chamizo A, Andújar Barroso RT.
europepmc +1 more source
Abstract Crimson clover (Trifolium incarnatum L.) is an obligately outcrossing, cool‐season annual legume valued for forage and cover cropping, yet genomic resources to support systematic improvement are limited. We performed the first whole‐genome re‐sequencing of global crimson clover germplasm to (i) develop a public mid‐density enrichment capture ...
Mark Philip Castillo +15 more
wiley +1 more source
Chronic Back Pain Increases Alzheimer's Disease Risk Independent of Gross Brain Structural Alterations: Genetic Evidence from Two Populations. [PDF]
Huang FF +11 more
europepmc +1 more source
Generalized prejudice and support for democracy among People of Color
Abstract The last decade of U.S. American political life has been described as “unprecedented times”. For many in the U.S., watching governmental norms erode and favor a select few elites over the common people signals that we are in a time of democratic backsliding.
Gretchen Nihill +2 more
wiley +1 more source
Chemoenzymatic Synthesis of Well-Defined α(2,8)- and α(2,9)-Linked Oligosialosides. [PDF]
Fok JA +4 more
europepmc +1 more source
Ewing Sarcoma in Infants and Children Under 2 Years of Age: A French Retrospective Study
ABSTRACT Ewing sarcoma, the second most common primary bone cancer in children, requires intensive treatment that may lead to significant long‐term sequelae, particularly in infants. We retrospectively analyzed data from 1621 French patients treated between 1988 and 2015 within the EW88/93/97 or EE99 trials, focusing on 17 infants diagnosed before 24 ...
Elodie Verdier +18 more
wiley +1 more source
Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric heart recipients were associated with impairment of the immune system - a multicenter study from Sweden. [PDF]
Ekman-Joelsson BM +9 more
europepmc +1 more source
Assessment of Lectin Staining Biomarkers for GNE Myopathy Gene Therapy
ABSTRACT Introduction/Aims GNE myopathy (GNEM) is a rare, autosomal recessive disorder caused by mutations in the UDP‐N‐acetylglucosamine (GlcNAc) 2‐epimerase/N‐acetylmannosamine (ManNAc) kinase (GNE) gene, which encodes a required enzyme for sialic acid (SA) biosynthesis.
Kristina M. Sattler +8 more
wiley +1 more source

